American Cancer Society. (2014, August 5). Ovarian Cancer. Retrieved from: http://www.cancer.org/acs/groups/cid/documents/webcontent/003130-pdf.pdf.
Cannistra SA, Gershenson DM, Recht A. Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. DeVita VT Jr, Lawrence TS, Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Edition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 76: 1075-1099.
Health Canada. (2015, September 28). Regulatory Decision Summary Avastin. Retrieved from: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/rds-sdr/drug-med/rds_sdr_avastin_171255-eng.php.
Health Canada. (2016, April 29). Regulatory Decision Summary: Lynparza. Retrieved from: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/rds-sdr/drug-med/rds-sdr-lynparza-182283-eng.php.
Health Canada. (2018, May 14). Lynparza - Notice of Compliance with Conditions - Qualifying Notice. Ottawa, ON: Health Canada.
National Cancer Institute. (2016, August 12). Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment for Health Professionals (PDQ®). Retrieved from: https://www.cancer.gov/types/ovarian/hp/ovarian-epithelial-treatment-pdq.×